January 18, 1992 |
A Food and Drug Administration advisory committee said Friday that a new drug to treat kidney cancer patients can have dangerous side effects but should be made available. In clinical tests, interleukin-2 reduced the size of cancerous tumors in 15% of patients, but it also caused severe toxic reactions in most who took it. The treatment was believed to have contributed to the deaths of 4% of the patients. The advisers recommended approval by a vote of 7 to 1. The National Kidney Cancer Assn.
August 11, 2005 |
Pfizer Inc. said it had asked U.S. regulators for permission to sell its experimental pill against cancers of the kidney and stomach, a product it is counting on to help restore earnings growth. Pfizer said it had asked the Food and Drug Administration to approve its Sutent pill to treat gastrointestinal stromal tumors, a type of stomach cancer, and kidney cancer that has spread to other parts of the body and has not been controlled by standard treatments. Shares of Pfizer fell 12 cents to $26.
September 25, 2006 |
Swedish women who ate fatty fish such as salmon, mackerel and herring at least once a week had a significantly lower risk of kidney cancer compared with consumers of lean fish, a new study has found. The 15-year study found those who regularly ate fish containing lots of fish oil that is rich in omega-3 acids and vitamin D had a 74% lower risk of getting kidney cancer compared with those who ate no fish at all.
April 30, 1994 |
A disabled gene that seems to let cells grow uncontrollably, like a car losing its brakes, is responsible for the most common form of kidney cancer, scientists reported Friday. Identification of the gene may lead to earlier detection of kidney cancer and possibly better treatment and prevention, said Dr. W. Marston Linehan of the National Cancer Institute, senior author of the study. The gene is one of a growing class of known "tumor suppressor" genes, which normally act to prevent cancer.
December 22, 2003 |
A new procedure could, for the first time, allow doctors to diagnose kidney cancer through a simple urine test. Until now, the only way to know if you had kidney cancer was with imaging tests, such as a CT scan, MRI or ultrasound and, if something suspicious was found, with a biopsy. Researchers at Fox Chase Cancer Center in Philadelphia have found that DNA testing of urine samples not only can accurately detect cancer but also can pick up the disease in its early stages, when it's curable.
CALIFORNIA | LOCAL
September 1, 2005 |
Steve Dunn, who fought back kidney cancer more than a decade ago and used his experience to launch a website to help others find appropriate treatments for the cancer, died Aug. 19 of complications from bacterial meningitis. He was 48. Dunn had been hospitalized with the disease for 10 months and died in a hospice in Denver, said his mother, Nancy Dunn. In August 1989 at age 32, Dunn, a computer programmer and avid outdoorsman, was diagnosed with advanced kidney cancer.